Dream Team
Asset Allocation
Position | Category/Sector | Target Weight |
---|---|---|
ABBNY ABB Ltd | Industrials | 15% |
AMLX Amylyx Pharmaceuticals, Inc. | Healthcare | 0.20% |
AQX.L Aquis Exchange plc | Financial Services | 7% |
AZN AstraZeneca PLC | Healthcare | 3% |
BNTX BioNTech SE | Healthcare | 8% |
NBIX Neurocrine Biosciences, Inc. | Healthcare | 1% |
NVO Novo Nordisk A/S | Healthcare | 3% |
NVS Novartis AG | Healthcare | 15% |
ORA.TO Aura Minerals Inc. | Basic Materials | 9% |
REL.L RELX PLC | Communication Services | 15% |
RGEN Repligen Corporation | Healthcare | 0.60% |
RHHBY Roche Holding AG | Healthcare | 2% |
SGOV iShares 0-3 Month Treasury Bond ETF | Government Bonds | 20% |
SNY Sanofi | Healthcare | 1.20% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Dream Team, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.
The earliest data available for this chart is Jan 7, 2022, corresponding to the inception date of AMLX
Returns By Period
YTD | 1M | 6M | 1Y | 5Y* | 10Y* | |
---|---|---|---|---|---|---|
^GSPC S&P 500 | -0.34% | -3.40% | 4.82% | 15.62% | 14.74% | 10.75% |
Dream Team | 6.58% | 2.10% | 4.06% | 22.88% | N/A | N/A |
Portfolio components: | ||||||
SGOV iShares 0-3 Month Treasury Bond ETF | 0.67% | 0.35% | 2.31% | 5.05% | N/A | N/A |
NVO Novo Nordisk A/S | 3.72% | 6.18% | -35.89% | -24.69% | 27.26% | 16.50% |
ABBNY ABB Ltd | 0.35% | -3.84% | -6.11% | 19.05% | 25.06% | 14.13% |
NVS Novartis AG | 11.93% | 5.82% | -9.90% | 11.99% | 11.01% | 6.42% |
RHHBY Roche Holding AG | 18.81% | 6.64% | -2.10% | 31.98% | 4.19% | 5.46% |
AZN AstraZeneca PLC | 17.08% | 9.20% | -12.45% | 20.29% | 14.19% | 11.65% |
SNY Sanofi | 12.25% | 3.82% | -3.77% | 13.15% | 6.37% | 4.73% |
REL.L RELX PLC | 4.95% | -3.59% | 2.57% | 11.03% | 17.72% | 15.47% |
BNTX BioNTech SE | -4.52% | -10.20% | 23.33% | 22.30% | 25.81% | N/A |
NBIX Neurocrine Biosciences, Inc. | -13.91% | -22.01% | -7.52% | -9.88% | 4.43% | 11.29% |
RGEN Repligen Corporation | 8.75% | -7.59% | 3.72% | -19.31% | 12.87% | 19.96% |
AMLX Amylyx Pharmaceuticals, Inc. | -16.40% | -8.67% | 42.34% | -83.24% | N/A | N/A |
ORA.TO Aura Minerals Inc. | 22.95% | 19.23% | 62.33% | 156.58% | 46.09% | 45.89% |
AQX.L Aquis Exchange plc | 1.76% | 1.90% | 73.46% | 94.35% | 13.05% | N/A |
Monthly Returns
The table below presents the monthly returns of Dream Team, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 4.89% | 6.58% | |||||||||||
2024 | 0.50% | 1.46% | 2.88% | 0.69% | 7.50% | 1.21% | 3.59% | 1.16% | 1.34% | -2.31% | 2.46% | -3.76% | 17.56% |
2023 | 6.72% | -2.97% | 4.89% | 4.13% | -4.05% | 3.20% | 2.84% | -2.85% | -0.76% | -1.74% | 7.40% | 3.73% | 21.53% |
2022 | -1.75% | -0.44% | 2.20% | -4.91% | 1.15% | -7.83% | 3.40% | -4.16% | -5.39% | 7.12% | 5.79% | -1.05% | -6.82% |
Expense Ratio
Dream Team has an expense ratio of 0.01%, which is considered low compared to other funds. Below you can find the expense ratios of portfolio funds side-by-side and effortlessly compare their relative costs.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 94, Dream Team is among the top 6% of portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
---|---|---|---|---|---|
SGOV iShares 0-3 Month Treasury Bond ETF | 20.96 | 482.78 | 483.78 | 494.51 | 7,850.08 |
NVO Novo Nordisk A/S | -0.92 | -1.19 | 0.84 | -0.72 | -1.49 |
ABBNY ABB Ltd | 0.85 | 1.22 | 1.16 | 1.59 | 3.84 |
NVS Novartis AG | 0.53 | 0.84 | 1.11 | 0.45 | 0.97 |
RHHBY Roche Holding AG | 1.28 | 1.83 | 1.25 | 0.68 | 3.17 |
AZN AstraZeneca PLC | 0.84 | 1.19 | 1.17 | 0.60 | 1.21 |
SNY Sanofi | 0.56 | 1.02 | 1.12 | 0.59 | 1.42 |
REL.L RELX PLC | 0.70 | 1.04 | 1.13 | 1.30 | 3.26 |
BNTX BioNTech SE | 0.43 | 1.03 | 1.12 | 0.30 | 1.76 |
NBIX Neurocrine Biosciences, Inc. | -0.35 | -0.21 | 0.96 | -0.49 | -0.95 |
RGEN Repligen Corporation | -0.44 | -0.39 | 0.95 | -0.40 | -0.83 |
AMLX Amylyx Pharmaceuticals, Inc. | -0.74 | -0.62 | 0.88 | -0.87 | -2.02 |
ORA.TO Aura Minerals Inc. | 3.19 | 3.51 | 1.46 | 4.87 | 23.00 |
AQX.L Aquis Exchange plc | 0.83 | 5.21 | 2.04 | 1.82 | 7.39 |
Dividends
Dividend yield
Dream Team provided a 2.59% dividend yield over the last twelve months.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Portfolio | 2.59% | 2.79% | 2.79% | 2.40% | 2.75% | 1.56% | 1.52% | 1.89% | 1.56% | 1.91% | 1.81% | 1.66% |
Portfolio components: | ||||||||||||
SGOV iShares 0-3 Month Treasury Bond ETF | 4.99% | 5.10% | 4.87% | 1.45% | 0.03% | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.62% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
ABBNY ABB Ltd | 1.85% | 1.86% | 2.07% | 2.91% | 2.41% | 2.79% | 3.34% | 4.38% | 2.84% | 3.80% | 4.59% | 3.73% |
NVS Novartis AG | 3.47% | 3.88% | 3.44% | 3.91% | 4.08% | 3.40% | 2.87% | 3.72% | 3.50% | 4.06% | 3.51% | 3.14% |
RHHBY Roche Holding AG | 3.36% | 3.99% | 3.55% | 3.23% | 2.47% | 2.63% | 2.69% | 3.58% | 3.22% | 3.62% | 3.14% | 3.23% |
AZN AstraZeneca PLC | 2.02% | 2.27% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% |
SNY Sanofi | 3.76% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
REL.L RELX PLC | 1.59% | 1.65% | 1.80% | 2.24% | 1.99% | 2.55% | 2.27% | 2.48% | 2.15% | 2.25% | 2.21% | 2.27% |
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 1.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RGEN Repligen Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AMLX Amylyx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ORA.TO Aura Minerals Inc. | 3.75% | 4.63% | 5.63% | 4.67% | 14.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AQX.L Aquis Exchange plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Dream Team. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Dream Team was 20.74%, occurring on Sep 26, 2022. Recovery took 138 trading sessions.
The current Dream Team drawdown is 2.74%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-20.74% | Jan 13, 2022 | 182 | Sep 26, 2022 | 138 | Apr 11, 2023 | 320 |
-6.52% | Aug 1, 2023 | 64 | Oct 27, 2023 | 19 | Nov 23, 2023 | 83 |
-5.1% | Jul 17, 2024 | 16 | Aug 7, 2024 | 8 | Aug 19, 2024 | 24 |
-5.02% | Sep 27, 2024 | 61 | Dec 20, 2024 | 29 | Feb 3, 2025 | 90 |
-4.64% | Apr 26, 2023 | 26 | May 31, 2023 | 13 | Jun 19, 2023 | 39 |
Volatility
Volatility Chart
The current Dream Team volatility is 3.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Diversification
Asset Correlations Table
SGOV | ORA.TO | AMLX | AQX.L | NBIX | BNTX | RGEN | NVO | SNY | REL.L | RHHBY | ABBNY | AZN | NVS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGOV | 1.00 | -0.03 | -0.04 | -0.04 | -0.02 | -0.02 | -0.05 | 0.01 | -0.01 | -0.03 | -0.01 | 0.02 | 0.02 | 0.03 |
ORA.TO | -0.03 | 1.00 | 0.10 | 0.13 | 0.07 | 0.08 | 0.11 | 0.07 | 0.07 | 0.13 | 0.14 | 0.25 | 0.11 | 0.09 |
AMLX | -0.04 | 0.10 | 1.00 | 0.04 | 0.27 | 0.21 | 0.26 | 0.15 | 0.11 | 0.08 | 0.15 | 0.19 | 0.14 | 0.15 |
AQX.L | -0.04 | 0.13 | 0.04 | 1.00 | 0.04 | 0.10 | 0.19 | 0.10 | 0.15 | 0.31 | 0.16 | 0.30 | 0.17 | 0.21 |
NBIX | -0.02 | 0.07 | 0.27 | 0.04 | 1.00 | 0.20 | 0.24 | 0.22 | 0.13 | 0.11 | 0.17 | 0.16 | 0.22 | 0.22 |
BNTX | -0.02 | 0.08 | 0.21 | 0.10 | 0.20 | 1.00 | 0.31 | 0.17 | 0.22 | 0.16 | 0.19 | 0.25 | 0.23 | 0.23 |
RGEN | -0.05 | 0.11 | 0.26 | 0.19 | 0.24 | 0.31 | 1.00 | 0.23 | 0.12 | 0.27 | 0.22 | 0.36 | 0.21 | 0.20 |
NVO | 0.01 | 0.07 | 0.15 | 0.10 | 0.22 | 0.17 | 0.23 | 1.00 | 0.27 | 0.28 | 0.30 | 0.28 | 0.41 | 0.37 |
SNY | -0.01 | 0.07 | 0.11 | 0.15 | 0.13 | 0.22 | 0.12 | 0.27 | 1.00 | 0.28 | 0.35 | 0.24 | 0.47 | 0.52 |
REL.L | -0.03 | 0.13 | 0.08 | 0.31 | 0.11 | 0.16 | 0.27 | 0.28 | 0.28 | 1.00 | 0.34 | 0.45 | 0.34 | 0.37 |
RHHBY | -0.01 | 0.14 | 0.15 | 0.16 | 0.17 | 0.19 | 0.22 | 0.30 | 0.35 | 0.34 | 1.00 | 0.31 | 0.43 | 0.51 |
ABBNY | 0.02 | 0.25 | 0.19 | 0.30 | 0.16 | 0.25 | 0.36 | 0.28 | 0.24 | 0.45 | 0.31 | 1.00 | 0.30 | 0.30 |
AZN | 0.02 | 0.11 | 0.14 | 0.17 | 0.22 | 0.23 | 0.21 | 0.41 | 0.47 | 0.34 | 0.43 | 0.30 | 1.00 | 0.54 |
NVS | 0.03 | 0.09 | 0.15 | 0.21 | 0.22 | 0.23 | 0.20 | 0.37 | 0.52 | 0.37 | 0.51 | 0.30 | 0.54 | 1.00 |